65,437 trials
Seasonal Allergic Rhinitis
Primary: Mean Change From Baseline in Daytime Nasal Symptoms Score — -0.32; -0.38; -0.47 Units on a Scale
Schizophrenia
Primary: Change in the PANSS Total Score From Baseline to the Last Postrandomization Assessment in the Double-blind Period of the Study. — -9.8; -17.3; -13.8; -7.9 units on a…
Asthma
Primary: Mean Percent Change From Baseline in Forced Expiratory Volume in 1 Second (FEV1) in Patients With Chronic Asthma — -11.96; -5.31; 0.72; 5.08 Percentage of Change
Neoplasms, Colorectal
Primary: Overall Response in Phase II — 2 participants
Contraception
Primary: Area Under the Concentration Versus Time Curve for 0 to 24 Hours After Drug Administration, Done Between Days 9 and 12 of the Menstrual Cycle at Time 1 (Before) and Time…
Myelodysplastic Syndromes
Primary: Participants Who Achieved Red Blood Cell (RBC) -Transfusion Independence — 59 participants
Upper Respiratory Tract Infections
Primary: Number of Subjects With an Investigator Assessment of Clinical Outcome (Success/Failure) at End of Study — 275; 133 participants
Cardiovascular Disease
Primary: Major Vascular Events (MVE) — 1553; 1477; 1537; 1493 Participants
Seasonal Allergic Rhinitis
Primary: Mean Change From Baseline in Daytime Nasal Symptoms Score Over First 2 Weeks of Treatment Period — -0.23; -0.33; -0.45 Scores on a scale
Crohn's Disease
Primary: Number of Participants Who Had Clinical Remission at Week 52 of Double-blind Treatment — 8; 2 Participants
Congestive Heart Failure
Primary: Percentage of Participants With First Occurrence of the Composite Outcome of Death (All Cause) or Protocol-Specified Cardiovascular (CV) Hospitalization at Given…
Diabetes Mellitus, Type 2
Primary: Change From Baseline in A1C at Week 24 — -0.61; -0.76; 0.18 Percent — p=<0.001
Hypertriglyceridemia · Hyperlipoproteinemia Type IV · Hyperlipoproteinemia Type V
Primary: Change (Reduction) in Triglycerides Levels From Baseline to End of Treatment (Week 8) — 67.95; 78.61; 22.31 mg/dL
Asymptomatic Bacteriuria
Primary: Antimicrobial Activity of Urine From Pregnant Subjects Following Cranberry Juice Cocktail (CJC) — 117.5; 105.0; 110.0 cfu per ml
Post-Operative Nausea and Vomiting
Primary: Number of Patients With Clinical Adverse Experiences (CAEs) — 125; 32 Participants